AlloVir
AlloVir (formerly ViraCyte) is a company that develops cell therapies for patients suffering from life-threatening virus-associated diseases.
3
Funding Rounds
$159.0m
Money raised
Overview
AlloVir (formerly ViraCyte) is a company that develops cell therapies for patients suffering from life-threatening virus-associated diseases.
-
Website:
- Business model: B2B
- Headquarters: Waltham, Massachusetts
- Social accounts:
| Name | Phone | Social networks | |
|---|---|---|---|
| An* Le** | - | - | |
| He*** He**** | - | - | |
| Ma Br | - | - | - |
| Jo** Wi**** |
|
- | |
| Ju** Ve** | - | - | linkedin instagram |
| Cl**** Ro**** | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Ma Br | - | - | - |
| Ju** Ve** | - | - | linkedin instagram |
| Da*** Ha**** |
|
- | |
| An Ga | - | - | |
| Je Bo** | - | - | |
| Sh*** To** | - | - | - |
| Mo**** Jo*** | - | - | |
| Di*** Br* | - | - | |
| Vi*** Si*** |
|
- |
Industries
AlloVir is active in the following industries: